𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel

✍ Scribed by Koutras, A K; Kotoula, V; Papadimitriou, C; Dionysopoulos, D; Zagouri, F; Kalofonos, H P; Kourea, H P; Skarlos, D V; Samantas, E; Papadopoulou, K; Kosmidis, P; Pectasides, D; Fountzilas, G

Book ID
126316873
Publisher
Nature Publishing Group
Year
2013
Tongue
English
Weight
1012 KB
Volume
14
Category
Article
ISSN
1470-269X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical factors associated with outcome
Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
✍ Toni K. Choueiri; Jorge A. Garcia; Paul Elson; Mohamad Khasawneh; Saif Usman; Al πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Therapy targeted against the vascular endothelial growth factor (VEGF) pathway is a standard of care for patients with metastatic renal cell carcinoma (RCC). The identification of patients who are more likely to benefit from these agents is warranted. ## METHODS. In to